Open AccessImpact of autoimmune demyelinating brain disease sera on pericyte survival
Author(s) -
Canan Ulusoy,
Emine Şekerdağ,
Vuslat Yılmaz,
Aysu Bilge Yilmaz,
Dila Atak,
Atay Vural,
Cem İsmail Küçükali,
Zerrin Karaaslan,
Murat Kürtüncü,
Recai Türkoǧlu,
Yavuz Özdemi̇r,
Erdem Tüzün
Publication year - 2020
Publication title -
nöropsikiyatri arşivi
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.417
H-Index - 14
ISSN - 1309-4866
DOI - 10.29399/npa.27350
Subject(s) - propidium iodide , experimental autoimmune encephalomyelitis , multiple sclerosis , myelin oligodendrocyte glycoprotein , pathogenesis , immunology , demyelinating disease , medicine , flow cytometry , pericyte , annexin , autoimmune disease , pathology , biology , apoptosis , antibody , programmed cell death , endothelial stem cell , biochemistry , in vitro
Multiple sclerosis (MS) is an autoimmune disease of the central nervous system (CNS) characterized by demyelination and brain pericyte dysfunction might be involved in MS pathogenesis Our aim was to evaluate whether the factors in serum affect pericyte survival.